EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

mTORC2 Regulates Non-homologous End Joining Through Modulating the Temporal Dynamics of 53BP1

Chunqing Wang, Hao Wang, Yunqiu Wang, Mingming Xiao, Xiaoxuan Song, Xiaofei Wang, Xiaofang Zhang, Kexing Jin, Dongqing Zhao, Hanxiang Chen, Ning Zhang, Ruibing Chen

Molecular & Cellular Proteomics · 2025

DOI: 10.1016/j.mcpro.2025.101035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Chunqing Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospi…. Hauptthemen laut MEDLINE: DNA End-Joining Repair, Tumor Suppressor p53-Binding Protein 1, Mechanistic Target of Rapamycin Complex 2, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Shandong First Medical University, Natural Science Foundation of Tianjin Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA damage repair is a critical biological process that maintains genomic integrity, and its dysregulation is closely related to tumorigenesis. To reveal the roles of mammalian target of rapamycin complex 2 (mTORC2) in DNA damage response (DDR), we investigated the temporal changes of cellular protein phosphorylation in mTORC2 deficient renal cancer cells in response to DNA double-strand break (DSB) induced by ionizing radiation (IR) using quantitative phosphoproteomics. The results showed that knockdown of Rictor, a specific component of mTORC2, induced profound changes in the dynamics of protein phosphorylation in response to IR. Intriguingly, the phosphorylation levels of multiple signaling molecules from the non-homologous end joining (NHEJ) pathway were affected by Rictor. Mechanistic study revealed that mTORC2 could regulate the spatiotemporal dynamics of p53 binding protein 1 (53BP1) in DDR. Rictor knockdown changed the phosphorylation of 53BP1 at multiple Ser/Thr sites. The efficiency of NHEJ was significantly reduced in Rictor deficient cells, and the maintenance of 53BP1 nuclear foci induced by IR was prolonged. Furthermore, mTORC2 modulated DSB repair through protein kinase B (PKB/Akt) and cyclin-dependent kinase 1 (CDK1). Finally, Rictor knockdown conferred hypersensitivity to IR and chemotherapeutic treatment in renal cancer cells, implying the potential use of the combination of mTORC2 inhibition with genotoxic therapy for renal cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA End-Joining RepairTumor Suppressor p53-Binding Protein 1Mechanistic Target of Rapamycin Complex 2TOR Serine-Threonine KinasesMultiprotein ComplexesHumansPhosphorylationDNA Breaks, Double-StrandedRapamycin-Insensitive Companion of mTOR ProteinCell Line, TumorCarrier ProteinsProto-Oncogene Proteins c-aktRadiation, IonizingSignal Transduction

Stichwörter der Autor:innen

53BP1DNA damage repairDNA double-strand breakmTORC2non-homologous end joiningphosphoproteomics

Substanzen

Tumor Suppressor p53-Binding Protein 1Mechanistic Target of Rapamycin Complex 2Rapamycin-Insensitive Companion of mTOR ProteinTP53BP1 protein, humanRICTOR protein, humanCarrier ProteinsProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesMultiprotein Complexes

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Laboratory Medicin…
  • The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.
  • Department of Clinical Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
  • Translational Cancer Research Center, Peking University First Hospital; International Cancer Institute, Peking University Health Science Center, Beijing, China; Yunnan Baiyao Group, Kunming, China. Electronic address: z…

Förderung

  • Natural Science Foundation of Shandong Province
  • Shandong First Medical University
  • Natural Science Foundation of Tianjin Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Wang, C., Wang, H., Wang, Y., Xiao, M., Song, X., Wang, X., Zhang, X., Jin, K., Zhao, D., Chen, H., Zhang, N., & Chen, R. (2025). mTORC2 Regulates Non-homologous End Joining Through Modulating the Temporal Dynamics of 53BP1. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2025.101035

Vancouver

Wang C, Wang H, Wang Y, Xiao M, Song X, Wang X, et al. mTORC2 Regulates Non-homologous End Joining Through Modulating the Temporal Dynamics of 53BP1. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2025.101035

BibTeX
@article{Wang2025,
  author = {Wang, Chunqing and Wang, Hao and Wang, Yunqiu and Xiao, Mingming and Song, Xiaoxuan and Wang, Xiaofei and Zhang, Xiaofang and Jin, Kexing and Zhao, Dongqing and Chen, Hanxiang and Zhang, Ning and Chen, Ruibing},
  title = {mTORC2 Regulates Non-homologous End Joining Through Modulating the Temporal Dynamics of 53BP1},
  journal = {Molecular & Cellular Proteomics},
  year = {2025},
  doi = {10.1016/j.mcpro.2025.101035}
}
Kostenlos starten →